Sphingosine-1-phosphate and Pneumonia

PHASE2/PHASE3RecruitingINTERVENTIONAL

Enrollment

400

Participants

Timeline

Start Date

June 15, 2019

Primary Completion Date

April 30, 2021

Study Completion Date

November 30, 2025

Conditions

Pneumonia, Bacterial

Interventions

DRUG

Methylprednisolone Sodium Succinate

methylprednisolone vial

DRUG

Placebo

Normal saline manufactured to mimic methylprednisolone vial

Trial Locations (1)

RECRUITING

Wan Fang Hospital, Taipei

All Listed Sponsors

lead

Taipei Medical University WanFang Hospital

OTHER